The Paragon Report Provides Stock Research on Goodrich Petroleum and Talisman Energy
Continue ReadingTag: stock-market
Biotech Industry Experiencing a Higher Amount of FDA New Drug Approvals in 2012
Five Star Equities Provides Stock Research on Discovery Laboratories and Cardium Therapeutics
Continue Reading
Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry-s Success in 2012
Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and AVEO Pharmaceuticals
Continue Reading
Gold Futures Surge to 1 Month Highs on Optimism That the Upcoming “Fiscal Cliff” Can Be Avoided
The Paragon Report Provides Stock Research on Newmont Mining and Goldcorp
Continue Reading
U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Forest Oil and Petroquest Energy
Continue Reading
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on CytRx and ZIOPHARM Oncology
Continue Reading
Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases
Five Star Equities Provides Stock Research on Orexigen Therapeutics and PDL BioPharma
Continue Reading
Increased Iron Ore Demand From China in the Fourth Quarter to Help Ease Shipping Industry-s Oversupply
Five Star Equities Provides Stock Research on Navios Maritime and Overseas Shipholding Group
Continue Reading
U.S. Foreign Oil Imports Projected to Decline by More Than 50% Within the Next Decade
The Paragon Report Provides Stock Research on Bill Barrett and EXCO Resources
Continue Reading
FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011
Five Star Equities Provides Stock Research on Astex Pharmaceuticals and Amicus Therapeutics
Continue Reading